Biochemical outcome for hormone-naı̈ve intermediate-risk prostate cancer managed with permanent interstitial brachytherapy and supplemental external beam radiation
- 31 December 2002
- journal article
- Published by Elsevier in Brachytherapy
- Vol. 1 (2) , 95-101
- https://doi.org/10.1016/s1538-4721(02)00016-8
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Five-year biochemical outcome following permanent interstitial brachytherapy for clinical T1-T3 prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 2001
- SIMULTANEOUS IRRADIATION FOR PROSTATE CANCER: INTERMEDIATE RESULTS WITH MODERN TECHNIQUESJournal of Urology, 2000
- Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 2000
- Modern prostate brachytherapyCancer, 2000
- Palladium-103 brachytherapy for prostate carcinomaPublished by Elsevier ,2000
- Seed fixity in the prostate/periprostatic region following brachytherapyInternational Journal of Radiation Oncology*Biology*Physics, 2000
- Prognostic role of serum prostatic acid phosphatase for 103Pd-based radiation for prostatic carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 1999
- Brachytherapy for clinically localized prostate cancer: Results at 7- and 8-year follow-upSeminars in Surgical Oncology, 1997
- Prostate Specific Antigen Based Disease Control Following Ultrasound Guided sup 125 Iodine Implantation for Stage T1/T2 Prostatic CarcinomaJournal of Urology, 1995
- Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43Medical Physics, 1995